Same Indication

Ipilimumab vs Telmisartan

Ipilimumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between Ipilimumab and Telmisartan.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Telmisartan — 24 hours.

Chemical Properties

Molecular Formula: Telmisartan — C33H30N4O2.

Molecular Weight: Telmisartan — 514.6230 g/mol.

Type: Ipilimumab — Antibody; Telmisartan — Small molecule.